Bon Natural Life (BON) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.14, +0.52% vs the prior close of $1.13.
- Volume 6.81K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BON rises 0.5% to $1.14. Closed at $1.14, +0.52% vs the prior close of $1.13. Day range $1.08β$1.14, opened at $1.10.
BON daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β BON rises 0.5% to $1.14
- Closed at $1.14, +0.52% vs the prior close of $1.13. Day range $1.08β$1.14, opened at $1.10.
- Volume was 6.81K shares, 0.8x its 50-day average of 8.49K.
- Price is -1.4% vs its 50-day average ($1.15) and -14.3% vs its 200-day average ($1.33).
- 52-week range $0.95β$2.25; today's close sits at 14% of that range, 49.5% below the 52-week high.
Oct 15, 2026 β BON ends flat (+0.0%) to $1.13
- Closed at $1.13, +0.00% vs the prior close of $1.13. Day range $1.11β$1.13, opened at $1.12.
- Volume was 8.30K shares, 1.0x its 50-day average of 8.39K.
- Price is -1.8% vs its 50-day average ($1.15) and -14.8% vs its 200-day average ($1.33).
- 52-week range $0.95β$2.33; today's close sits at 13% of that range, 51.5% below the 52-week high.
Oct 14, 2026 β BON rises 0.9% to $1.13
- Closed at $1.13, +0.89% vs the prior close of $1.12. Day range $1.08β$1.14, opened at $1.08.
- Volume was 10.00K shares, 1.2x its 50-day average of 8.44K.
- Price is -1.7% vs its 50-day average ($1.15) and -15.0% vs its 200-day average ($1.33).
- 52-week range $0.95β$2.34; today's close sits at 13% of that range, 51.7% below the 52-week high.
Oct 13, 2026 β BON dips 0.8% to $1.12 on 4.8x normal volume
- Closed at $1.12, -0.80% vs the prior close of $1.13. Day range $1.10β$1.15, opened at $1.14.
- Volume was 37.40K shares, 4.8x its 50-day average of 7.80K β unusually heavy trading.
- Price is -2.5% vs its 50-day average ($1.15) and -15.9% vs its 200-day average ($1.33).
- 52-week range $0.95β$2.34; today's close sits at 12% of that range, 52.1% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 β BON dips 2.7% to $1.13 on 2.0x normal volume
- Closed at $1.13, -2.67% vs the prior close of $1.16. Day range $1.12β$1.15, opened at $1.15.
- Volume was 15.10K shares, 2.0x its 50-day average of 7.60K β unusually heavy trading.
- Price is -1.7% vs its 50-day average ($1.15) and -15.4% vs its 200-day average ($1.33).
- 52-week range $0.95β$2.34; today's close sits at 13% of that range, 51.8% below the 52-week high.
Oct 9, 2026 β BON dips 0.6% to $1.16
- Closed at $1.16, -0.60% vs the prior close of $1.17. Day range $1.14β$1.18, opened at $1.15.
- Volume was 4.60K shares, 0.6x its 50-day average of 7.67K β lighter than usual.
- Price is +1.1% vs its 50-day average ($1.15) and -13.2% vs its 200-day average ($1.34).
- 52-week range $0.95β$2.34; today's close sits at 15% of that range, 50.4% below the 52-week high.
Oct 8, 2026 β BON rises 0.6% to $1.17
- Closed at $1.17, +0.60% vs the prior close of $1.16. Day range $1.15β$1.17, opened at $1.17.
- Volume was 1.60K shares, 0.2x its 50-day average of 7.76K β lighter than usual.
- Price is +1.8% vs its 50-day average ($1.15) and -12.8% vs its 200-day average ($1.34).
- 52-week range $0.95β$2.34; today's close sits at 16% of that range, 50.1% below the 52-week high.
Oct 7, 2026 β BON dips 0.9% to $1.16
- Closed at $1.16, -0.85% vs the prior close of $1.17. Day range $1.16β$1.18, opened at $1.16.
- Volume was 4.70K shares, 0.6x its 50-day average of 7.84K β lighter than usual.
- Price is +1.3% vs its 50-day average ($1.15) and -13.5% vs its 200-day average ($1.34).
- 52-week range $0.95β$2.34; today's close sits at 15% of that range, 50.4% below the 52-week high.
Oct 6, 2026 β BON ends flat (-0.1%) to $1.17
- Closed at $1.17, -0.09% vs the prior close of $1.17. Day range $1.15β$1.18, opened at $1.15.
- Volume was 6.50K shares, 0.8x its 50-day average of 7.97K.
- Price is +2.2% vs its 50-day average ($1.15) and -12.9% vs its 200-day average ($1.34).
- 52-week range $0.95β$2.34; today's close sits at 16% of that range, 50.0% below the 52-week high.
Oct 5, 2026 β BON rises 2.7% to $1.17 on 3.1x normal volume
- Closed at $1.17, +2.72% vs the prior close of $1.14. Day range $1.01β$1.18, opened at $1.13.
- Volume was 23.20K shares, 3.1x its 50-day average of 7.57K β unusually heavy trading.
- Price is +2.3% vs its 50-day average ($1.14) and -13.1% vs its 200-day average ($1.35).
- 52-week range $0.95β$2.34; today's close sits at 16% of that range, 50.0% below the 52-week high.
Oct 2, 2026 β BON slides 3.1% to $1.14, 4 down days in a row
- Closed at $1.14, -3.06% vs the prior close of $1.18. Day range $1.12β$1.19, opened at $1.19.
- Volume was 4.80K shares, 0.6x its 50-day average of 8.10K β lighter than usual.
- Price is -0.3% vs its 50-day average ($1.14) and -15.5% vs its 200-day average ($1.35).
- 52-week range $0.95β$2.34; today's close sits at 14% of that range, 51.3% below the 52-week high.
- That makes 4 straight losses.
BON latest news & SEC filings
Every SEC filing by or about BON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade BON
- How much it moves: over the last 20 sessions the average daily move was 1.13% (largest 3.1%).
- Liquidity: about 10.66K shares (β$12.10K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.14 vs a range of $0.95β$2.25 (14% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on May 19, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 23, 2026; 6-K Mar 19, 2026; 6-K Feb 17, 2026.
- Listing: Nasdaq Β· industry: Medicinal Chemicals & Botanical Products.
BON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.10 | 1.14 | 1.08 | 1.14 | 6.81K |
| Oct 15, 2026 | 1.12 | 1.13 | 1.11 | 1.13 | 8.30K |
| Oct 14, 2026 | 1.08 | 1.14 | 1.08 | 1.13 | 10.00K |
| Oct 13, 2026 | 1.14 | 1.15 | 1.10 | 1.12 | 37.40K |
| Oct 12, 2026 | 1.15 | 1.15 | 1.12 | 1.13 | 15.10K |
| Oct 9, 2026 | 1.15 | 1.18 | 1.14 | 1.16 | 4.60K |
| Oct 8, 2026 | 1.17 | 1.17 | 1.15 | 1.17 | 1.60K |
| Oct 7, 2026 | 1.16 | 1.18 | 1.16 | 1.16 | 4.70K |
| Oct 6, 2026 | 1.15 | 1.18 | 1.15 | 1.17 | 6.50K |
| Oct 5, 2026 | 1.13 | 1.18 | 1.01 | 1.17 | 23.20K |
| Oct 2, 2026 | 1.19 | 1.19 | 1.12 | 1.14 | 4.80K |
| Oct 1, 2026 | 0.95 | 1.20 | 0.95 | 1.18 | 16.70K |
| Sep 30, 2026 | 1.19 | 1.21 | 1.18 | 1.20 | 2.40K |
| Sep 29, 2026 | 1.20 | 1.21 | 1.18 | 1.20 | 5.80K |
| Sep 28, 2026 | 1.19 | 1.22 | 1.15 | 1.22 | 6.00K |
| Sep 25, 2026 | 1.18 | 1.21 | 1.18 | 1.20 | 5.60K |
| Sep 24, 2026 | 1.17 | 1.21 | 1.17 | 1.21 | 3.80K |
| Sep 23, 2026 | 1.21 | 1.22 | 1.15 | 1.20 | 12.20K |
| Sep 22, 2026 | 1.19 | 1.23 | 1.19 | 1.21 | 12.60K |
| Sep 21, 2026 | 1.20 | 1.22 | 1.17 | 1.21 | 25.00K |
About Bon Natural Life
Bon Natural Life (BON) is listed on the Nasdaq and classified by the SEC under βMedicinal Chemicals & Botanical Productsβ. Its business address is in SHAANXI, China. State of incorporation: Cayman Islands. Fiscal year ends September 30. SEC CIK 1816815.
BON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jing Veronica Chen | Director | Apr 23, 2026 |
| Jianjun Gao | Director | Apr 10, 2026 |
| Yongwei Hu | Chief Executive Officer | Apr 10, 2026 |
| Gao Zhixiang | Director | May 15, 2026 |
| Jing Liu | Chief Technology Officer | Apr 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yongwei Hu | Chief Executive Officer | Apr 10, 2026 |
| Xin Ma | Chief Financial Officer | Apr 10, 2026 |
| Chen Wenjuan | Chief Marketing Officer | Apr 10, 2026 |
| Yingchun Xue | Chief Operating Officer | Apr 10, 2026 |
| Jing Liu | Chief Technology Officer | Apr 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
BON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Cronos (CRON)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Canopy Growth (CGC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.